Biliary tract disease describes any disease that affects the biliary tract the gall bladder, bile ducts and accompanying structures. Examples include primary sclerosing cholangitis, secondary ...
Cancer is a major medical problem worldwide. Due to its high heterogeneity, the use of the same drugs or surgical methods in patients with the same tumor may have different curative effects, leading ...
a risk factor for cancer. Renaming DCIS is an “ethical imperative,” she has argued, to spare patients undue anxiety and to shift the current treatment paradigm from invasive surgery to active ...
The study was published in the top journal Nature Cancer. In the study Talimogene Laherparepvec (TVEC) was used, which has so far only been approved for the treatment of superficial melanoma ...
By harnessing gold nanoparticles coupled with the HN-1 peptide, this innovative system ... in cancer nanotherapy." The Au-HN-1 nanosystem could transform the landscape of TSCC treatment and ...
How cancer ‘poisons’ the immune system Cancer cells can sabotage immune cells that try to attack them by filling them with defective mitochondria, the organelles that cells rely on to make energy.
Following on from the University of Cincinnati trial, oncologists are also hopeful that Flash machines could improve the treatment of various forms of metastatic disease (where the cancer has ...
the treatment also releases toxins that can kill neighboring cancer cells. Additionally, destroying the support cells weakens the tumor structure, making it easier for the body's immune system to ...
Jan. 21, 2025 -- The FDA has approved a new treatment for patients with a common form of breast cancer that has spread to other parts of the body or cannot be surgically removed. The drug ...
AstraZeneca’s (AZ) Imfinzi (durvalumab) has been approved in the European Union (EU) as first-line treatment of adult patients with unresectable or metastatic biliary tract cancer (BTC ...
inoperable biliary tract cancer," Shroff said. "Our research also indicates that the three-drug regimen may increase the toxicity of the treatment." Shroff noted that the three-drug regimen might ...
Background: Immune checkpoint blockade (ICB)-based immunotherapy has inspired new hope for advanced biliary tract cancer (BTC) treatment; however, there are no prior studies that primarily focus on ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果